Subscribe

Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks
AstraZeneca Commits ₹176 Cr to Expand Chennai Tech Hub in India
pharma-industry business earnings

AstraZeneca Commits ₹176 Cr to Expand Chennai Tech Hub in India

Newsdesk profile image
by Newsdesk
Updated

AI-Generated Summary

Global bio-pharmaceutical company AstraZeneca has committed ₹176 crore in India, specifically for the expansion of its Global Innovation and Technology Centre (GITC) in Chennai. This investment, announced during the Tamil Nadu government's 'TN Rising London' campaign, aims to advance healthcare technology and innovation. It marks AstraZeneca's third significant investment in India recently, reinforcing its focus on the region.

In a nutshell

This latest investment highlights AstraZeneca's strategic commitment to leveraging India's technological capabilities and talent for global healthcare innovation. It positions Chennai as a key hub for the company's R&D efforts and reflects a broader trend of multinational pharmaceutical firms expanding their presence in emerging markets.

Source: Outlook Business

Newsdesk profile image
by Newsdesk
Updated

Be informed!

Rx.news delivers critical healthcare intelligence to pharmaceutical professionals, biotech innovators, healthcare investors, medical practitioners, and policy makers.

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Read More